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Abstract
Background: Compounds having both anticancer and antimicrobial activity have promising therapeutic potential
due to their selective cytotoxicity and their potential to reduce the occurrence of bacterial and fungal infections in
immune-compromised cancer patients. In our quest to find new antimicrobial agents with potent anticancer
activity, the biological potential of leaves from the three medicinal plants Centella asiatica, Warburgia salutaris and
Curtisia dentata as used by Zulu traditional healers for the treatment of cancer is investigated.
Methods: Extracts were assayed for antibacterial activity using the agar well diffusion and micro plate dilution
assay. In addition, minimum bactericidal concentrations (MBC), lactate dehydrogenase (LDH) release assay and
rhodamine 6G intake assay were used to ascertain the antibacterial activity. The cytotoxic effects of the plant
extracts were determined using tetrazolium-based colorimetric (MTT) cell proliferation assay against MCF-7, human
colorectal carcinoma cells (Caco-2), A549 and HeLa cancerous cell lines.
Results: The acetone extracts from Waburgia salutaris revealed noteworthy anti-proliferative effect yielding IC50
value of 34.15 μg/ml against MCF-7 cell line, while acetone extract from Curtisia dentata significantly (P≤ 0.05)
revealed promising IC50 values of 41.55, 45.13, 57.35 and 43.24 μg/ml against A549, HeLa, CaCo-2 and MCF-7 cell
lines. The extracts further revealed a broad-spectrum antibacterial activity against bacterial strains used in the study.
An acetone extract from W. salutaris revealed the highest zone of inhibition and the lowest minimum inhibitory
concentration (MIC) of 21.0 mm and 0.16 mg/ml respectively against Staphylococcus aureus. Methanol extract from
W. salutaris and ethyl acetate extract from C. dentata revealed 53% inhibition of R6G inside the cell against
Staphylococcus aureus and Escherichia coli respectively in a cytosolic lactate dehydrogenase assay, suggesting that
the mode of action of such extracts may be through efflux pump.
Conclusions: Overall, the extracts had good antibacterial activity and anti-proliferative effects against selected
cancerous cell lines. Given the good antibacterial activity of the extracts the plants may act as an immune booster
and prevent infection in immunosuppressed cancer patients. This is further supported by the plants’ anti-
proliferative potential, bacteriostatic, bactericidal properties and also their ability to block bacterial efflux pump
systems.
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Background
Chemopreventive agents from medicinal plants are being
sought after as a promising approach to control and man-
age life-threatening human infections like cancer [1, 2].
Studies of various medicinal plants and other natural
products from nature have shown the anti-proliferative,
cytostatic and cytotoxic activities of various phytochemi-
cals against different cancer cells [3]. Traditional African
medicine is amongst the most ancient natural therapies
and the oldest form of medicine currently used. Combined
with western drugs, it can be used to produce one of the
most successful regimes to treat a variety of illnesses [4].
Traditional African medicine is based on using botanical
preparations to treat human and animal illness. Such
medicine is prepared by extracting roots, barks, leaves,
flowers, seeds from, or the entire plant of, different plant
species [5]. Different types of plants contain a variety of
phytochemicals, which may well act as antioxidants, anti-
microbial, anti-inflammatory and anti-cancer agents, mak-
ing the use of plants more advantageous [6]. Furthermore,
these plants generally possess little or no side effects when
compared to western medicine. Immunosuppression is
the suppression of the immune system’s ability to fight
infection. This is often caused by diseases like HIV/AIDS,
lymphoma and cancer. Immunosuppression is a major
complication in cancer and also an adverse effect of
chemotherapy during the treatment of cancer. Most
patients being treated with broad-based chemotherapy
develop immunosuppression. Chemotherapy treatment is
intended to target rapidly dividing cells. Unfortunately, it
does not discriminate between cancer cells and other
rapidly dividing cells. The body’s immune system cells are
equally rapidly dividing and may unfortunately become
the target of chemotherapy. This invariably exposes pa-
tients receiving chemotherapy to infection. The most
common clinical manifestation of immunosuppression is
infection, which may be bacterial, viral, or fungal [7–10].
Centella asiatica (L.) Urb, Warburgia salutaris (Bertol. f.)
Chiov and Curtisia dentata (Burm. F.) C.A.Sm are African
medicinal plants which are generally used by traditional
healers for the treatment and management of cancer
[11–14]. C. asiatica is from the Araliaceae family and
its leaves are used for the treatment of fever, rheuma-
toid arthritis and skin related disorders [13–15]. W.
salutaris is from the Canellaceae family and used in the
treatment of malaria, venereal diseases, cancer, coughs
and colds [11, 16, 17]. C. dentata belongs to the Corna-
ceae family and its stem, bark and leaves are used in the
treatment of cancer, stomach disorders, diarrhoea, sexu-
ally transmitted diseases and as a blood purifier [14, 18].
In the current study, we evaluate the antibacterial activ-
ities of these medicinal plants, as used in the treatment of
cancer by traditional healers in South Africa against noso-
comial pathogenic bacterial strains due to the fact that the
most common clinical manifestation of immunosuppres-
sion is bacterial infection.
Method
Plant materials
The leaves of C. asiatica, W. salutaris and C. dentata were
collected from the South African National Biodiversity
Institute (SANBI) Lowveld Botanical Garden in Nelspruit,
South Africa. The voucher specimens of C. asiatica, W.
salutaris and C. dentata were prepared and matched with
voucher specimen numbers Glow 12/2011, Glow 167/1988
and Glow 96/1998 respectively within Lowveld Herbarium.
The plant materials were identified by Willem Froneman
the resident horticulturist.
Extraction
The plant leaves were dried at room temperature and
powdered using a hammer mill (Ika Scientific, Germany)
to yield approximately 2 mm mesh size powder. The
leaves of each plant were soaked (1:10 w/v) in metha-
nol, ethyl acetate, dichloromethane and distilled water
respectively in 200 ml Schott Duran bottles. The
bottles were placed in in mechanical shaker (IKA Sci-
entific, Model MF 10 B, Germany) at 100 rpm for 48 h
to extract the phytochemicals. The extracts were fil-
tered through a Whatman No.1 filter paper, and then
concentrated and dried using a Buchi rotoary evapor-
ator. The water extracts were dried using a bench top
freeze dryer (Labconco Corporation, Kansas City,
Moussouri, USA) after being frozen at 20 °C. All the
solvents used were of AR grade and obtained from
Merck, South Africa.
Microorganisms
A total of fourteen microorganisms were selected and
used in the study. The organisms were collected from the
University of South Africa, College of Agriculture and
Environmental Sciences Laboratories. Enterococcus avium
(ATCC 14025), Staphylococcus aureus (ATCC 6538),
Streptococcus agalactiae (ATCC 12386), Bacillus cereus
(ATCC 10702), Enterococcus hirae (ATCC 10541), Entero-
coccus faecalis (Clinical isolate), Enterococcus gallinarium
(ATCC 49573), Escherichia coli (ATCC 25922), Pseudo-
monas aeruginosa (ATCC 10031), Proteus mirabilis ATCC
(29906), Proteus vulgaris ATCC (49132), Klebsiella pneu-
moniae (ATCC 13883), Acinetobacter calcaoceuticus ani-
tratus (CSIR) and Salmonella typhi (ATCC 14028) were
selected for the study. The stock cultures were maintained
at 4 °C in Müeller-Hinton agar (Oxoid, Germany).
Antibacterial assay
Agar disk diffusion
The study of antibacterial activity of the selected medi-
cinal plant extracts was carried using the agar disk
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diffusion method [19]. Bacterial strains were grown over-
night at 37 °C separately in 10ml nutrient broth. The bac-
teria cultures were then diluted to the McFarland no.5
standard (1.0 × 108 CFU/ml). Bacteria suspension (1.0 × 108
CFU/ml) were then inoculated with into standard Petri
dishes with nutrients agar. Sterile paper disks of 6 mm
(Mast Diagnostics, Germany) were placed on the inocu-
lated plates after which the paper disk were soaked with
10 μl of 10 mg/ml of the extracts in 1% DMSO. Tests
were performed in triplicates. Zones of inhibition were
measured in mm as a diameter in areas where no
growth of the bacteria was visible.
The minimum inhibitory concentration (MIC)
The MIC of the extracts was determined using the
micro plate dilution assay [20]. Nutrients broth (50 μl)
was added into all the wells of the 96 well microtitre
plate. About 50 μl of all the extracts (5 mg/ml) in 1%
DMSO was then serially diluted down the rows from
row of the 96 well microtitre plate. Bacterial culture
(50 μl) of McFarland standard was then added to all
the wells of the 96 well microtitre plate then incu-
bated at 37 °C for 24 h. p-Iodo-nitrotetrazolium violet
(INT) solution (40 μl of 0.2 mg/ml) was then added
into all the well of the 96 well microtitre plate and
incubated at 37 °C for 30 min. The MIC was defined
as the lowest concentration with no visible microbial
growth observed within the plate.
The minimum bactericidal concentration (MBC)
Minimum bactericidal concentration is defined as the
lowest concentration of the plant extract where all the
inoculated bacterial strains are completely killed. Culture
medium 10 μl from the microtiter plates used for MIC
was reinoculating, on nutrient agar plates and incubated
at 37 °C for 24 h. [21].
Lactate dehydrogenase (LDH) release assay (membrane
damage)
The cytosolic LDH release assay was done using micro-
plate technique previously described [22–25]. The LDH
release assay was calculated with the formula: (E-C)/
(T-C) × 100, where E is the absorbance of the experi-
mental cell cultures, C is the absorbance of the cell
medium used as the control, and T the absorbance of
the positive control which is the LDH release of Triton
X-100 lysed cells.
Rhodamine 6G uptake
The extracts were tested for their Efflux pump inhibitory
activity using the method of Maesaki et al. (1999) [26]
with some modifications as described by Soyingbe et al.
(2015) [50]. The percentage accumulation of R6G inside
cells after exposure to glucose, essential oil and stan-
dards was calculated from the formula:
Percentage accumulation of R6G ¼ 1−At=Aoð Þ x 100ð Þ
Where At is the absorbance of the test compound and
Ao is the absorbance of the control in the presence of
glucose only.
Cytotoxity assay
Human breast adenocarcinoma (MCF-7) cells, human
cervical cancer cells (HeLa), human embryonic kidney
cells (HEK293) and human colorectal carcinoma cells
(Caco-2) were grown to confluency in 75 cm3 flasks. The
cells were then trypsinised and plated into 96 well plates
at specific seeding densities of 23 × 104 cells per well,
incubated overnight at 37 °C and 5% CO2. The medium
was then removed and fresh medium (MEM+Glutmax +
antibiotics+ 10% Fetal bovine serum) was added. Extracts
were then added in triplicate and incubated for 48 h. At
the end of the incubation period, test samples were re-
moved from the wells and replaced with 200 μl fresh
medium to which 30 μl of 5 mg/ML MTT was added and
incubated for 4 h. After incubation with MTT, the
medium in each well was removed and the formazan crys-
tals that formed were dissolved by adding 50 μL of DMSO
to each well of the plates. The plates were gently shaken
until the crystals dissolved. The amount of MTT reduc-
tion was measured immediately by detecting the absorb-
ance at 570 nm [27]. The percentage of cell viability was
calculated using the formula below:
%Cell viability ¼ Mean absorbance of sample
=Mean absorbance of control X 100
The IC50 values (lethal concentration at which 50% of
the cells are killed) were calculated from linear regression
plots as the concentration of the test sample that resulted
in 50% reduction of absorbance compared to untreated
cells. The intensity of the MTT formazan produced by
living metabolically active cells is directly proportional to
the number of live cells present.
Statistical analysis
The results of each assay was analyzed using Graphpad
Prism 6, data were expressed as means ± SD of triplicate
measurements. P values ≤0.05 were referred to as statis-
tically significant.
Results
The antibacterial activity of the plant extracts against
14 bacterial strains, is shown in Table 1. In the agar
diffusion assay, the selected medicinal plants showed a
broad-spectrum antibacterial activity against both gram
positive and gram negative organism with zones of
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inhibition ranging from 7mm to 29 mm. The methanol
extracts of C. asiatica and C. dendata, had the highest
antibacterial activity yielding 10 mm to 19 mm. The in-
hibitory zone of 8 mm to 21 mm was observed for the
acetone extract of W. salutaris. The minimum inhibi-
tory concentration (MIC) activity of methanol, ethyl
acetate acetone and water leaf extracts of C. asiatica,
W. salutaris and C. dentata are presented in Table 2.
The MIC values of the extracts ranged from 0.31 mg/ml
to >10 mg/ml. The methanol extract of W. salutaris
revealed a lowest MIC value of 0.31 mg/ml against E.
avium and E. coli, while the acetone extracts had an
MIC value of 0.31 mg/ml on E.coli. The MIC value of
0.31 mg/ml for the methanol extract of C. dentata on
Staphylococcus aureus was also noted. The cytosolic
lactate dehydrogenase release which measures the mem-
brane damage is shown in Table 3. Only extracts that
showed MBC activities were tested for their LDH release
activity. The highest cytosolic lactate dehydrogenase re-
lease ranged from 0 to 36.4% release. The accumulation of
R6G in the cells after exposure to glucose, plant extracts
and standard inhibitor berberine are presented in Table 3.
Insofar as the LDH activity was concerned, only extracts
with MBC values were tested further for their efflux pump
inhibitory activity. The value of the drug accumulation in
the presence of glucose alone was taken as the control 0%.
The accumulation range was from 0 to 53%, with the ethyl
acetate extract of C. dentata showing a high efflux pump
inhibitory capacity. The results of the cytotoxicity
investigations are presented in Table 4 and the cytotoxic
effects of the plant extracts were tested against 4 cell line.
The IC50 values of the extracts, which is the lethal concen-
tration at which 50% of the cells are killed (calculated as
the average from three independent experiments) against
doxorubicin hydrochloride as a reference drug, are
represented in Table 4. C. asiatica acetone extract
showed the most significant activity, with IC50 value of
53.65 ± 0.06 μg/ml against MCF-7 and 46. 49 ± 0.04 μg/ml
for A549. The water extracts were the least active and
showed IC50 value of >100 μg/ml for MCF-7, Caco-2 and
A549 and IC50 value of 76.3 ± 0.06 μg/ml for HeLa. The
acetone extracts from C. dentata and W. salutaris revealed
the most active cytotoxic effect. Acetone extracts from
C. dentata exhibited IC50 values of 43.24 ± 0.01 and
41.55 ± 0.04 μg/ml against MCF-7 and A549 respect-
ively, while the acetone extract from W. salutaris revealed
IC50 values of 34.15 ± 0.77 and 44.51 ± 1.25 μg/ml against
A549 and MCF-7 respectively. The methanol and ethyl
acetate extracts from C. dentata revealed IC50 values
ranging from 53.27 ± 0.76 μg/ml to 82.6 ± 0.13 μg/ml
against the four selected cell lines.
Discussion
Natural products which are obtained from medicinal
plants, extracted in their crude form or as purified iso-
lates, have been used as bases for discovering new drugs
because of their chemical diversity. Interest and demand
are on the rise for the chemical diversity applied in
Table 2 The MIC (mg/ml) values of Centella asiatica, Curtisia dentate and Warbugia salutaris extracts against bacteria
Centella
Asiatica
Curtisia
Dentate
Warburgia
salutaris
Controls
Test organisms Methanol Ethyl
Acetate
Acetone water Methanol Ethyl
Acetate
Acetone water Methanol Ethyl
Acetate
Acetone water Cipro 1% DMSO
E. avium 2.5 5 2.5 >10 0.63 5 0.63 5 0.31 1.25 1.25 10 0.63 ND
S. aureus 2.5 1.25 1.25 5 0.31 2.5 0.63 5 1.25 1.25 0.16 5 0.16 ND
S. agalactiae 5 5 5 >10 0.63 5 1.25 >10 5 >10 1.25 5 2.5 ND
B. cereus 2.5 2.5 1.25 5 0.63 5 1.25 5 1.25 5 1.25 10 0.63 ND
E. hirae 2.5 5 1.25 >10 1.25 5 5 5 1.25 2.5 2.5 5 5.0 ND
E. faecalis 5 10 5 10 >10 >10 5 >10 >10 >10 5 >10 0.63 ND
E. gallinarium 1.25 5 2.5 5 1.25 5 5 >10 2.5 2.5 5 5 0.31 ND
E. Coli 1.25 5 0.63 >10 0.63 2.5 1.25 10 0.31 2.5 0.31 5 0.31 ND
P. aeruginosa 5 10 5 10 1.25 >10 0.63 >10 2.5 >10 2.5 10 1.25 ND
P. mirabilis 2.5 >10 5 >10 0.63 5 1.25 >10 2.5 5 2.5 >10 0.31 ND
P. vulgaris 5 5 2.5 10 5 5 2.5 10 >10 5 5 10 1.25 ND
K. pneumonia >10 >10 5 >10 >10 >10 5 >10 2.5 5 5 >10 5.0 ND
Acinetobacter
Calcaoceuticals
Anitratus
5 >10 >10 >10 5 >10 >10 >10 5 >10 2.5 >10 5.0 ND
S. typhi >10 >10 >10 >10 5 >10 5 >10 5 >10 >10 >10 2.5 ND
MIC values given as mg/ml, results are mean of three replicates, ND = not determined, DMSO = Dimethyl sulfoxide; Cipro = Ciprofloxacin. (P ≤ 0.05)
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screening programs. The quest for therapeutic drugs ob-
tained from natural products, particularly edible plants,
has grown throughout the world [28, 29]. In this study
we investigated the antibacterial and cytotoxicity proper-
ties of 3 important medicinal plants used in the treat-
ment of cancer by traditional healers in South Africa
against nosocomial pathogenic bacteria. Treatments
using herbal medicines provide some advantages over
the use of single purified chemicals [15, 30]. This could
be because herbal medicines are mixtures of different
therapeutic or preventive compounds or components,
and could provide more activity in treating diseases than
single products on their own [4, 31]. The dried plant
leaves materials were extracted using different solvents,
ethyl acetate, acetone, methanol and water. Water being
the preferred solvent used by most traditional healers
because of its availability. However, water does not ex-
tract non-polar bio-active compounds. Hence, in our
study we decided to use other solvents to extract all
compounds of varying polarities. The methanol and
acetone extracts were the most active, as compared to
the ethyl acetate and water extracts. These findings are
similar to those of other authors [32] who reported that
the methanol leaf extract of C. asiatica has moderate
Table 3 Antibacterial percentage cytosolic lactate dehydrogenase assay and percentage accumulation of R6G inside the cell after
exposure to glucose, plant extract and standard inhibitor bererine
Percentage accumulation and release
Centella asiatica Curtisia dentate Warburgia salutaris Control
Test organisms Methanol Ethyl
Acetate
Acetone Water Methanol Ethyl
Acetate
Acetone water Methanol Ethyl
Acetate
Acetone water berberine
E. avium LDHa 0.68 – 0 – 8.1 – 0.7 – 2.4 – 0 – 53
R6Gb 11 31 10 – 30 – 24 – 3 – 21 –
S. aureus LDHa 0 0.3 3.6 – 7.2 2.1 5.4 – 0.8 0 36.4 – 87
R6Gb 20 42 5 – 9 35 25 – 53 20 6 –
S. agalactiae LDHa – – – – – – 0.7 – 0.5 – 1.4 – 76
R6Gb – – – – – – 14 – 15 – 3 –
B. cereus LDHa – 0.8 4.3 – 1.4 – – – 15.1 – 0.3 – 85
R6Gb – 39 13 – 12 – – – 10 – 8 –
E. hirae LDHa – – – – – – – – – 0 0.1 – 75
R6Gb – – – – – – – – – 24 9 –
E. faecalis LDHa – – – – – – – – – – 1.0 – 67
R6Gb – – – – – – – – – – 6 –
E. gallinarium LDHa 0 – – – – – 5.1 – 1.6 – – – 55
R6Gb 9 – – – – – 18 – 23 – – –
E. Coli LDHa 0.8 – 18.6 – 1.4 0 18.6 – 25.4 1.34 4.3 – 92
R6Gb 11 – 45 – 31 53 39 – 35 24 11 –
P. aeruginosa LDHa – – – – – – 4.4 – 3.3 – 0.9 – 64
R6Gb – – – – – – 51 – 24 – 7 –
P. mirabilis LDHa – – – – 0.7 – – – – – – – 41
R6Gb – – – – 18 – – – – – – –
P. vulgaris LDHa – – 0 – – – – – – – – – 50
R6Gb – – 6 – – – – – – – – –
K. pneumonia LDHa – – – – – – – – 4.7 0 – – 79
R6Gb – – – – – – – – 6 – –
Acinetobacter
Calcaoceuticals
Anitratus
LDHa – – – – – – – – – – 0 – 66
R6Gb – – – – – – – – – – 23 –
S. typhi LDHa – – – – – – – – – – 0 – 45
R6Gb – – – – – – – – – – 11 –
aLDH release (membrane damage) activity % LDH Release in comparison to Triton X-100; bValues of drug accumulation in the presence of glucose were taken as
the control, − = not determined. (P ≤ 0.05)
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antibacterial activity against Staphylococcus aureus, Ba-
cillus cereus, Pseudomonas aeruginosa and Escherichia
coli, while the acetone extract was less effective against
these same organisms. In other studies [33] the metha-
nol extract of C. asiatica leaves revealed the highest
inhibitory activity when compared to the acetone and
aqueous extracts. Additionally, Waburgia ugandensis
which had a similar composition pattern of its essential
oil with W. salutaris, inhibited gram positive bacteria S.
aureus and Streptococcus pnemoniae which were the
most sensitive to the extract [34].
Elsewhere, W. salutaris showed high antibacterial ac-
tivity against test bacteria and its methanol extract was
the only extract that showed activity against Escherichia
coli, a gram negative organism [35]. Higher antimicrobial
activity of methanol extracts from W. salutaris could be
related to sesquiterpene dialdehydes which are known to
have antibacterial and cytotoxic activities and previously
isolated from other taxonomically related Waburgia
species [36]. Muzigadial was also identified as the main
antibacterial agent in the stem bark of W. salutaris [16],
with MIC of 12.5 μg/ml against both S. aureus and B.
subtilis similar to the present study. Results of anti-
microbial potentials of C. dentata against E. coli sero-
types ranged between 8 and 28% which is similar to this
present study similarly other authors [37, 38] reported
MIC values using C. dentata methanol extracts that
agree with the present study [39]. The positive control
ciprofloxacin was also active against all the 14 organisms
tested, whilst 1% DMSO and the negative control i.e.
sterile distilled water were both not active on any of the
14 organisms tested.
The MBC values shown in Table 5 ranged between
2.5 mg/ml and 10mg/ml. The lowest MBC value of 2.5
mg/ml was observed in the methanol and acetone ex-
tracts of W. salutaris on E. coli, while only the acetone
extract of W. salutaris had an MBC value of 2.5 mg/ml
on S. aureus. The water extracts showed no bactericidal
activities and are therefore not shown.
The highest release of 36.4% was revealed by the acet-
one extract of W. salutaris on S. aureus (Table 3). This
could be attributed to the fact that gram positive organ-
isms possess a single layer cell membrane, and more
susceptible to antibiotics compared to gram negative
organisms, that have a double membrane and are less
susceptible to the effect of antimicrobial agents [40].
Although most studies show that essential oils disrupt
the permeability barrier of bacteria cell membranes [41].
The results of the membrane damage activity in this
study show a low membrane damage activity similar to
that reported by other authors [42]. The LDH release ac-
tivity values of the extracts are generally low which
shows that the mode of action of the extracts are not
through membrane damage of the bacteria cells.
The efflux pump confers bacterial resistance [43]. The
development of new antibiotics which act as efflux pump
inhibitors (EPIs) is very important in order to reduce the
emergence of multidrug resistance (MDR) to the present
Table 5 The MBC (mg/ml) values of Centella asiatica, Curtisia dentate and Warbugia salutaris extracts against bacteria
Centella
Asiatica
Curtisia
Dentate
Warburgia
salutaris
Controls
Test organisms Methanol Ethyl
Acetate
Acetone water Methanol Ethyl
Acetate
Acetone water Methanol Ethyl
Acetate
Acetone water Cipro 1% DMSO
E. avium 5 >10 10 >10 2.5 >10 10 >10 5 >10 10 >10 0.63 ND
S. aureus 10 5 5 >10 5 10 5 >10 10 10 2.5 >10 0.16 ND
S. agalactiae >10 >10 >10 >10 >10 >10 10 >10 10 >10 5 >10 2.5 ND
B. cereus >10 10 2.5 >10 10 >10 >10 >10 5 >10 5 >10 0.63 ND
E. hirae >10 >10 >10 >10 >10 >10 >10 >10 >10 10 10 >10 5.0 ND
E. faecalis >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 10 >10 0.63 ND
E. gallinarium 10 >10 >10 >10 >10 >10 10 >10 10 >10 >10 >10 0.31 ND
E. Coli 5 >10 5 >10 10 5 5 >10 2.5 5 2.5 >10 0.31 ND
P. aeruginosa >10 >10 >10 >10 >10 >10 10 >10 10 >10 10 >10 1.25 ND
P. mirabilis >10 >10 >10 >10 5 >10 >10 >10 >10 >10 >10 >10 0.31 ND
P. vulgaris >10 >10 10 >10 >10 >10 >10 >10 >10 >10 >10 >10 1.25 ND
K. pneumonia >10 >10 >10 >10 >10 >10 >10 >10 10 10 >10 >10 5.0 ND
Acinetobacter
Calcaoceuticals
Anitratus
>10 >10 >10 >10 >10 >10 >10 >10 >10 >10 10 >10 5.0 ND
S. typhi >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 2.5 ND
MBC values given as mg/ml, results are mean of three replicates ND = not determined, DMSO = Dimethyl sulfoxide; Cipro = Ciprofloxacin. (P ≤ 0.05)
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antibiotics being used. Recent studies have shown that me-
dicinal plants have bioactive compounds (such as tannins,
alkaloids, flavonoids etc) responsible for antibacterial prop-
erties [44]. The accumulation of R6G was species specific,
as observed in the current study. These results were in
accordance with results found by other authors [45], which
showed that R6G concentration are increase with plant ex-
tracts. S. aureus was noted to have the highest percentage
accumulation when compared with other organisms.
In a study carried out by Babu et al., 1995 [46], purified
fractions of C. asiatica showed anti-proliferative effects
having IC50 values of 17 μg/mL and 22 μg/mL against
Ehrlich ascites tumor cells, which agrees with our study.
On the other hand, Pittella et al. 2009 [47] showed aque-
ous extracts of C. asiatica to reveal no anti-proliferative
activity against mouse melanoma (B16F1), human breast
cancer (MDA MB-231) and rat glioma (C6) cell lines with
IC50 value of 698.0 μg/mL, 648.0 μg/mL and 1000.0 μg/mL
respectively. Betulinic acid was found to be the most
abundant of the isolated compounds, present in most of
the bulk fractions of C. dentata [38]. Betulinic acid was se-
lectively cytotoxic against several human melanoma can-
cer cell lines. It was also found to be active in vivo against
athymic mice carrying human melanoma with little tox-
icity [48]. The mechanism of action of betulinic acid on
mammalian cells is thought to involve the induction of
apoptosis [48]. By the standard set by National Cancer In-
stitute, a crude extract is said to have anti-tumor proper-
ties when exhibiting the IC50 value of less than 50 μg/ml
[49], suggesting that the extracts from the selected medi-
cinal plants revealed some anti-cancer effects against the
selected cell lines.
Conclusion
It is imperative that more drugs be discovered to combat
the upsurge of cancer. Medicinal plants are being sought
after as the potential way forward in treating cancer and
also the underlying effects of cancer treatments. The
methanol extracts of C. Dentate and W. Salutaris showed
the highest antibacterial activity while the acetone extract
of W. Salutaris showed the most promising cytotoxicity
effect. Given the good antibacterial activity of the extracts
the plants may act as an immune booster and prevent
infection in immunosuppressed cancer patients. This may
also be due to their bacteriostatic and bactericidal activ-
ities, and also their ability to block bacterial efflux pump
systems. With the plant extracts showing a good overall
antibacterial activity and moderate cytotoxic effect in this
study, the results of this study suggest that the different
extracts have the potential to be exploited as a good
source for the development of antimicrobial agents.
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